Trials / Completed
CompletedNCT00751998
Spy II Clinical Registry
A Clinical Registry to Assess Performance and Clinical Utility of the SpyGlass Direct Visualization System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 297 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SpyGlass | The SpyGlass Direct Visualization System is an integrated product platform that is designed to provide a direct intraluminal view of the biliary duct system and direct therapeutic devices. |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-04-01
- Completion
- 2009-10-01
- First posted
- 2008-09-12
- Last updated
- 2021-08-19
- Results posted
- 2011-04-12
Locations
15 sites across 6 countries: United States, Belgium, Denmark, France, Germany, Italy
Source: ClinicalTrials.gov record NCT00751998. Inclusion in this directory is not an endorsement.